Stocks Cheap After First-Quarter Plummet
Two thirds of the stocks in our North American coverage are undervalued, trading at 4 or 5 stars.
Two thirds of the stocks in our North American coverage are undervalued, trading at 4 or 5 stars.
The global COVID-19 pandemic has swiftly reversed our view of the North American equity market. Amid virus and related economic concerns, the Morningstar US Market Index has plummeted roughly 20% from the end of 2019. And although we have lowered many of our fair value estimates, the market drop has revealed numerous buying opportunities across sectors. The median stock in our North American equity coverage now trades at a 22% discount to our fair value estimate compared with the 3% premium at the end of last year. Of the roughly 800 North American stocks we cover, a hefty 67% have an undervalued rating of 4 or 5 stars, whereas three months ago, only about 20% were undervalued. Excluding utilities, the median stock in the other 10 sectors we follow trades at a more than 10% discount to intrinsic value. The market hasn’t been this heavily discounted in many years.
Two Thirds of Our North American Coverage Is Undervalued - source: Morningstar
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.